Commission: Jessica Eye tested positive for marijuana following UFC 166

The banned substance UFC women’s bantamweight Jessica Eye tested positive for in the wake of UFC 166 was marijuana, according to an order from the Texas Department of Licensing and Regulation obtained by FOXSports.com.

Eye, who earned a split-decision over Sarah Kaufman at the Oct. 19 pay-per-view event, specifically tested positive for cannabinoids, according to the order, which changed the result of the fight to a no-decision and handed the 27-year-old fighter a yearlong “probated suspension” and $1,875 in fines, payable in eight installments.

BloodyElbow.com originally reported that Eye’s positive test was caused by marijuana following a brief from Bleacher Report that said an undisclosed blood-thinner medication was responsible for the failure.

Eye (10-1 MMA, 1-0 UFC), who despite her suspension is scheduled to fight Alexis Davis (15-5 MMA, 2-0 UFC) at UFC 170, today told MMAFighting.com that she made a “mistake” related to disclosure to the TDLR. She denied using performance-enhancing drugs.

As part of a settlement agreement obtained by FOX, which was inked on Jan. 14, Eye waived her right to an appeal of the decision. The document contradicts an interview she gave this past week to MMAjunkie in which she said she wasn’t suspended “at all” and would seek to protect her win.

The agreement also calls for Eye to notify the commission’s “enforcement prosecutor” of any upcoming fights and their subsequent drug test results, as well as to remain in compliance with “all laws and rules” of the TDLR. Any violations of the agreement, the agreement states, will result in the revocation of her probated suspension, which began Jan. 22. It will also trigger a separate six-month suspension.

Eye’s order said she provided two urine samples prior to UFC 166, and her samples were tested by LabCore, an independent testing facility.

For the latest on UFC 170, stay tuned to the UFC Rumors section of the site.